Enoxolone Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: by Product (Injection, Tablet, Other); End User (Peptic Ulcer Teatment, Antitussive, Other), and Geography (North America, Europe, Asia Pacific, and South and Central America)

MARKET INTRODUCTION

Enoxolone is a pentacyclic triterpenoid derivative of the beta-amyrin type that is obtained from the hydrolysis of glycyrrhizic acid, which was obtained from the herb liquorice. However, it is used in flavoring, and it masks the bitter taste of drugs like aloe and quinine. It is useful in the treatment of peptic ulcers and also has expectorant (antitussive) properties. It has some additional pharmacological properties with possible antiviral, antifungal, antiprotozoal, and antibacterial activities.

MARKET DYNAMICS

The enoxolone market is driving due to the rising geriatric population and growing prevalence of chronic diseases. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and increase in research funding contribute to the growth of the market for enoxolone.

MARKET SCOPE

The "Enoxolone Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of enoxolone market with detailed market segmentation by of product, and end user. The enoxolone market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in enoxolone market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The enoxolone market is segmented on the basis of product, and end user. Based on product, the market is segmented as injection, tablet and other. On the basis of end user, the market is categorized as peptic ulcer treatment, antitussive and other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the enoxolone market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The enoxolone market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting enoxolone market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the enoxolone market in these regions.

MARKET PLAYERS

The report covers key developments in the enoxolone market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from enoxolone market are anticipated to have lucrative growth opportunities in the future with the rising demand for enoxolone in the global market. Below mentioned is the list of few companies engaged in the enoxolone market.

The report also includes the profiles of key players in enoxolone market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Alchem International
  
•   Alps Pharmaceutical
  
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Enoxolone Report Scope

The List of Companies

1. Alchem International
2. Alps Pharmaceutical